Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|November 16, 2020
Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different MutationsMarika Colombo, Mirko Marabese, Giulia Vargiu, et al.
American Journal of Cancer Research|January 8, 2021
Molecular determinants of response to PI3K/akt/mTOR and KRAS pathways inhibitors in NSCLC cell linesAlice Iezzi, Elisa Caiola, Marika Colombo, et al.
American Journal of Cancer Research|March 23, 2026
Erratum: Molecular determinants of response to PI3K/AKT/mTOR and KRAS pathways inhibitors in NSCLC cell linesAlice Iezzi, Elisa Caiola, Marika Colombo, et al.
Cells|July 29, 2020
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine ExploitationElisa Caiola, Marika Colombo, Giovanna Sestito, et al.
Frontiers in Oncology|June 1, 2022
LKB1: Can We Target an Hidden Target? Focus on NSCLCGloriana Ndembe, Ilenia Intini, Elisa Perin, et al.
Cells|December 11, 2022
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2)Marika Colombo, Federico Passarelli, Paola A Corsetto, et al.
International Journal of Molecular Sciences|January 25, 2025
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian CarcinomaSerena Petrella, Marika Colombo, Mirko Marabese, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 22, 2019
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK InhibitorsElisa Caiola, Alice Iezzi, Michele Tomanelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 11, 2021
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical modelsLavinia Morosi, Marina Meroni, Paolo Ubezio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2021
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based TreatmentsCristina Borzi, Monica Ganzinelli, Elisa Caiola, et al.
Pageof 1